249 related articles for article (PubMed ID: 31541110)
21. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
[TBL] [Abstract][Full Text] [Related]
22. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
23. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
24. Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies.
Serrano-Collazo C; Pérez-Guzmán EX; Pantoja P; Hassert MA; Rodríguez IV; Giavedoni L; Hodara V; Parodi L; Cruz L; Arana T; Martínez MI; White L; Brien JD; de Silva A; Pinto AK; Sariol CA
PLoS Negl Trop Dis; 2020 May; 14(5):e0008285. PubMed ID: 32463814
[TBL] [Abstract][Full Text] [Related]
25. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
26. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
27. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
[TBL] [Abstract][Full Text] [Related]
28. CD4
Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
[TBL] [Abstract][Full Text] [Related]
29. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines.
Valiant WG; Mattapallil MJ; Higgs S; Huang YS; Vanlandingham DL; Lewis MG; Mattapallil JJ
Sci Rep; 2019 May; 9(1):7877. PubMed ID: 31133721
[TBL] [Abstract][Full Text] [Related]
31. Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.
Masel J; McCracken MK; Gleeson T; Morrison B; Rutherford G; Imrie A; Jarman RG; Koren M; Pollett S
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007060. PubMed ID: 30682026
[TBL] [Abstract][Full Text] [Related]
32. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
[TBL] [Abstract][Full Text] [Related]
33. Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.
Andrade P; Gimblet-Ochieng C; Modirian F; Collins M; Cárdenas M; Katzelnick LC; Montoya M; Michlmayr D; Kuan G; Balmaseda A; Coloma J; de Silva AM; Harris E
Nat Commun; 2019 Feb; 10(1):938. PubMed ID: 30808875
[TBL] [Abstract][Full Text] [Related]
34. Immune Response to Dengue and Zika.
Ngono AE; Shresta S
Annu Rev Immunol; 2018 Apr; 36():279-308. PubMed ID: 29345964
[TBL] [Abstract][Full Text] [Related]
35. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
[TBL] [Abstract][Full Text] [Related]
36. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
37. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
[TBL] [Abstract][Full Text] [Related]
38. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.
Katzelnick LC; Bos S; Harris E
Curr Opin Virol; 2020 Aug; 43():59-70. PubMed ID: 32979816
[TBL] [Abstract][Full Text] [Related]
39. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
40. An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.
Lang J; Cheng Y; Rolfe A; Hammack C; Vera D; Kyle K; Wang J; Meissner TB; Ren Y; Cowan C; Tang H
Stem Cell Reports; 2018 Aug; 11(2):348-362. PubMed ID: 29983385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
